Tesla-SpaceX Merger Committees Formed as $16.8B Terafab Chip Plant Confirmed
TSLA sits 26% above its 52-week low of $297.38.
Summary
Tesla and SpaceX have formed special committees to explore a merger, but talks are preliminary with no deal, timeline or approval in place; valuation gaps, regulatory review and China operations are the named hurdles. Lawmakers have pledged congressional antitrust and national security scrutiny ahead of the November midterms, and SpaceX currently fails S&P 500 listing criteria. Separately, Tesla confirmed Terafab, a roughly $16.8B Texas chip project targeting more than 1 terawatt of AI compute a year, with a test chip in H1 2027 and volume production in Q3 2028. The Q3 print showed revenue of $28.05B, GAAP net income of $787M and free cash flow of $1.53B, with 2026 capex cut to about $20B. Megapack capacity is nearly sold out through 2027 at roughly 110 GWh nameplate, and FSD has about 1.74M active subscribers generating close to $1B annualized. The merger question is the swing factor: a stock-for-stock combination could create roughly 10% passive demand for combined TSLA shares, but political opposition makes near-term completion unlikely.
At the time of this announcement, TSLA was trading at $373.35 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $1.5T. The 52-week trading range was $297.38 to $498.83. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.